[29-412-pm] Antibacterial, antiviral and antifungal agents 2/Vaccines and bioactive agents

[29-412-pm17] Identification of broad neutralizing antibody against SARS-CoV-2 variants including EG.5.1.

○HANAKO ISHIMARU¹, Mitsuhiro Nishimura¹, Hideki Shigematsu², Maria Istiqomah Marini¹, Natsumi Hasegawa¹, Rei Takamiya¹, Sachiyo Iwata³, Yasuko Mori¹ (1. Division of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, 2. Structural Biology Division, Japan Synchrotron Radiation Research Institute SPring-8, 3. Division of Cardiovascular Medicine, Hyogo Prefectural Kakogawa Medical Center)